NASDAQ: NTLA

Financial Scores

NTLA’s price-to-sales ratio: Is it a good investment opportunity?

Cameron Mitchell

Intellia Therapeutics Inc (NTLA)’s stock has witnessed a price hike of 3.56% from the previous close with its current price ...

Market Summary

Is NTLA’s price to cash per share ratio a concern for investors?

Patricia Turner

Intellia Therapeutics Inc (NTLA)’s stock is trading at $9.48 at the moment marking a fall of -2.27% from the last ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.